Oppenheimer & Co’s Concentrix CNXC Stock Holding History

Oppenheimer & Co’s Portfolio CNXC Stock Details CNXC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,124	Closed	-$553K	–	1497
2021 Q3	$553K	Buy	+3,124	New	+$518K	0.01%	976

Other funds holding CNXC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Oppenheimer & Co's CNXC Position: Q4 2021 in Review

Oppenheimer & Co sold out of Concentrix (CNXC) in Q4 2021, closing a stake of 3,124 shares — an estimated $553K sold.

Oppenheimer & Co first reported a position in CNXC in Q3 2021 and held it in 1 quarter. The position peaked at $553K in Q3 2021. 345 funds tracked by Wall St. Rank hold CNXC as of Q4 2021.

Oppenheimer & Co reported no remaining Concentrix position as of Q4 2021 after selling out during the quarter.
Oppenheimer & Co sold 3,124 Concentrix shares in Q4 2021, an estimated $553K.
Oppenheimer & Co first reported a position in Concentrix in Q3 2021 and held it in 1 quarter.
Oppenheimer & Co's Concentrix position peaked at $553K in Q3 2021.
345 funds tracked by Wall St. Rank held Concentrix as of Q4 2021.

Based on Oppenheimer & Co's 13F filing for Q4 2021, filed 2 Feb 2022.